Annualized recurring revenue (“ARR”) of $777 million, an increase of 14% year-over-year Total revenue of $199 million, up 13% year-over-year; Products revenue of $190 million, up 14% year-over-year GAAP operating loss of $16 million; Non-GAAP operating …
SAN DIEGO and GAINESVILLE, Ga., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing …
Izzy Martins to be appointed EVP & CFO and Brian Choi to be appointed EVP & Chief Transformation Officer Jagdeep Pahwa to become Chairman and Bernardo Hees to continue as Board Member PARSIPPANY, N.J., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Avis Budget …
Nan Xiang Xiao Long Bao Partners with Asian Americans for Equality (AAFE) to Empower the Flushing Community NEW YORK, NY, UNITED STATES, November 1, 2023 /EINPresswire.com/ -- Nan Xiang Xiao Long Bao, a culinary landmark in Flushing, New York, is …
BURLINGTON, Mass., Nov. 01, 2023 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q3 2023 results, announced a $0.14/share quarterly dividend and provided guidance. Q3 2023 Financial Results …
Third Quarter Highlights Net revenues increased +16.3% driven by Organic Net Revenue1 growth of +15.7% with strong +3.8pp Volume/Mix performance, Volume/Mix positive across all regions Diluted EPS was $0.72, up +84.6%; Adjusted EPS1 was $0.82, up +16.7% on …
NEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) -- New York Mortgage Trust, Inc. (Nasdaq: NYMT) (“NYMT,” the “Company,” “we,” “our” or “us”) today reported results for the three and nine months ended September 30, 2023. Summary of Third Quarter 2023: (dollar …
Added 386 new enterprise platform customers and 58 net new six-figure customers. Revenue of $201.5 million, up 15% year-over-year. Calculated current billings of $224.7 million, up 8% year-over-year. Net cash provided by operating activities of $42.4 …
SANTA CLARA, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- SiTime Corporation, (Nasdaq: SITM), the precision timing company, today announced financial results for the third quarter ended September 30, 2023. Net revenue in the third quarter of 2023 was $35.5 …
PARSIPPANY, N.J., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) announced financial results for third quarter 2023 today. We ended the quarter with revenues of $3.6 billion, driven by peak demand and seasonal revenue per day …
BALA CYNWYD, Pa., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that members of the company’s …
COVINGTON, La., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Pool Corporation (Nasdaq:POOL) announced today that it will participate in the following investor events in the fourth quarter of 2023: November 8, 2023 – Baird 2023 Global Industrial Conference November 14 …
SAN JOSE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Adeia Inc. (Nasdaq: ADEA) has been recognized on Newsweek’s inaugural list of the World’s Most Trustworthy Companies 2023. This prestigious recognition is presented by Newsweek and Statista Inc., the …
CAMBRIDGE, Mass., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO) (Spero), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and commercializing treatments in high unmet need areas …
MENLO PARK, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrine, oncology, metabolism and neurology …
BERKELEY, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced the company’s participation in the following investor conferences: …
BURLINGTON, Mass., Nov. 01, 2023 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce …
SOUTH SAN FRANCISCO, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO), a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, today announced that …
Dallas, Texas, Nov. 01, 2023 (GLOBE NEWSWIRE) -- CompX International Inc. (NYSE American: CIX) announced today that its board of directors has declared CompX’s regular quarterly dividend of twenty-five cents ($0.25) per share on its class A common stock, …
VANCOUVER, British Columbia, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Looking Glass Labs Ltd. (“LGL” or the “Company”) (NEO: NFTX) (AQSE: NFTX) (OTC: LGSLF) (FRA: H1N), a leading Web3 platform specializing in non-fungible token (“NFT”) architecture, immersive …
